Regulators of genetic risk of breast cancer identified by integrative network analysis

Genetic risk for breast cancer is conferred by a combination of multiple variants of small effect. To better understand how risk loci might combine, we examined whether risk-associated genes share regulatory mechanisms. We created a breast cancer gene regulatory network comprising transcription factors and groups of putative target genes (regulons) and asked whether specific regulons are enriched for genes associated with risk loci via expression quantitative trait loci (eQTLs). We identified 36 overlapping regulons that were enriched for risk loci and formed a distinct cluster within the network, suggesting shared biology. The risk transcription factors driving these regulons are frequently mutated in cancer and lie in two opposing subgroups, which relate to estrogen receptor (ER)+ luminal A or luminal B and ER− basal-like cancers and to different luminal epithelial cell populations in the adult mammary gland. Our network approach provides a foundation for determining the regulatory circuits governing breast cancer, to identify targets for intervention, and is transferable to other disease settings.

[1]  B. Raught,et al.  C/EBPbeta, but not C/EBPalpha, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. , 1998, Genes & development.

[2]  Brian Raught,et al.  C/EBPβ, but not C/EBPα, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland , 1998 .

[3]  Y. Benjamini,et al.  THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .

[4]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[5]  Adam A. Margolin,et al.  Reverse engineering of regulatory networks in human B cells , 2005, Nature Genetics.

[6]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[8]  Daniel Birnbaum,et al.  Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. , 2006, Cancer research.

[9]  Paul Schliekelman,et al.  Statistical Power of Expression Quantitative Trait Loci for Mapping of Complex Trait Loci in Natural Populations , 2008, Genetics.

[10]  Marie-Liesse Asselin-Labat,et al.  The Ets transcription factor Elf5 specifies mammary alveolar cell fate. , 2008, Genes & development.

[11]  Michael D. Wilson,et al.  ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions. , 2009, Methods.

[12]  S. Fox,et al.  Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers , 2009, Nature Medicine.

[13]  J. Uhm,et al.  The transcriptional network for mesenchymal transformation of brain tumours , 2010 .

[14]  A. Ashworth,et al.  BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. , 2010, Cell stem cell.

[15]  Sarah L Vowler,et al.  Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer. , 2010, Genes & development.

[16]  Elgene Lim,et al.  Open Access Research Article Transcriptome Analyses of Mouse and Human Mammary Cell Subpopulations Reveal Multiple Conserved Genes and Pathways , 2022 .

[17]  W. Tilley,et al.  Breast and prostate cancer: more similar than different , 2010, Nature Reviews Cancer.

[18]  Wing-Kin Sung,et al.  Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state , 2011, Molecular systems biology.

[19]  I. Mills,et al.  Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1 , 2011, The EMBO journal.

[20]  Charles M Perou,et al.  Systems biology and genomics of breast cancer. , 2011, Cold Spring Harbor perspectives in biology.

[21]  David Venet,et al.  Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome , 2011, PLoS Comput. Biol..

[22]  A. Rocha,et al.  Distinct stem cells contribute to mammary gland development and maintenance , 2011, Nature.

[23]  Wonshik Han,et al.  NFIB is a potential target for estrogen receptor‐negative breast cancers , 2011, Molecular oncology.

[24]  E. Dermitzakis,et al.  From expression QTLs to personalized transcriptomics , 2011, Nature Reviews Genetics.

[25]  S. A. Andres,et al.  Relationships of ESR1 and XBP1 expression in human breast carcinoma and stromal cells isolated by laser capture microdissection compared to intact breast cancer tissue , 2011, Endocrine.

[26]  C. Perou,et al.  Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch , 2011, Proceedings of the National Academy of Sciences.

[27]  Kevin R Brown,et al.  Essential gene profiles in breast, pancreatic, and ovarian cancer cells. , 2012, Cancer discovery.

[28]  A. Butte,et al.  Leveraging models of cell regulation and GWAS data in integrative network-based association studies , 2012, Nature Genetics.

[29]  J. Carroll,et al.  Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? , 2012, Molecular endocrinology.

[30]  F. Markowetz,et al.  RedeR: R/Bioconductor package for representing modular structures, nested networks and multiple levels of hierarchical associations , 2012, Genome Biology.

[31]  Swneke D. Bailey,et al.  Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression , 2012, Nature Genetics.

[32]  R. Ophoff,et al.  Unraveling the Regulatory Mechanisms Underlying Tissue-Dependent Genetic Variation of Gene Expression , 2012, PLoS genetics.

[33]  Andrey A. Shabalin,et al.  Matrix eQTL: ultra fast eQTL analysis via large matrix operations , 2011, Bioinform..

[34]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[35]  Adelaide I J Young,et al.  ELF5 Suppresses Estrogen Sensitivity and Underpins the Acquisition of Antiestrogen Resistance in Luminal Breast Cancer , 2012, PLoS biology.

[36]  C. Caldas,et al.  Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland , 2012, Breast Cancer Research.

[37]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[38]  Gurkan Bebek,et al.  FOXA1 Represses the Molecular Phenotype of Basal Breast Cancer Cells , 2012, Oncogene.

[39]  J. Taube,et al.  Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas. , 2013, Human pathology.

[40]  H. Kiaris,et al.  Notch3 marks clonogenic mammary luminal progenitor cells in vivo , 2013, The Journal of cell biology.

[41]  A. McKenna,et al.  Integrative eQTL-Based Analyses Reveal the Biology of Breast Cancer Risk Loci , 2013, Cell.

[42]  Vignette for RTN : reconstruction of transcriptional networks and analysis of master regulators , 2013 .

[43]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[44]  Mark Gerstein,et al.  A comprehensive nuclear receptor network for breast cancer cells. , 2013, Cell reports.

[45]  Benjamin J. Raphael,et al.  Network analysis of GWAS data. , 2013, Current opinion in genetics & development.

[46]  Jaana M. Hartikainen,et al.  Large-scale genotyping identifies 41 new loci associated with breast cancer risk , 2013, Nature Genetics.

[47]  Kerstin B. Meyer,et al.  Master regulators of FGFR2 signalling and breast cancer risk , 2013, Nature Communications.

[48]  K. Pietras,et al.  MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer , 2013, Oncogene.

[49]  G. Mills,et al.  YB‐1 Transforms Human Mammary Epithelial Cells Through Chromatin Remodeling Leading to the Development of Basal‐Like Breast Cancer , 2014, Stem cells.

[50]  Carolina E. Pardo,et al.  TRIM29 suppresses TWIST1 and invasive breast cancer behavior. , 2014, Cancer research.

[51]  F. Reyal,et al.  Luminal Progenitors Restrict Their Lineage Potential during Mammary Gland Development , 2015, PLoS biology.

[52]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[53]  Alison M Dunning,et al.  From candidate gene studies to GWAS and post-GWAS analyses in breast cancer. , 2015, Current opinion in genetics & development.

[54]  Mingming Jia,et al.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..